Stay updated on AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial
Sign up to get notified when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.

Latest updates to the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page
- Check4 days agoChange DetectedTwo new study sites were added (St. Louis, Missouri and Neptune City, New Jersey), expanding the trial's geographic footprint. Two sites were removed (Maplewood, Missouri and West Long Branch, New Jersey), updating the list of participating sites.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3 tag as part of a minor update to the site's revision history.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision/version label was updated from v3.5.2 to v3.5.3, indicating an internal site build update rather than a modification to the clinical trial details.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.5.2 replaces the previous revision label v3.5.0.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision history updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision: v3.4.3 was added; Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AXS-12 in Narcolepsy: Efficacy & Safety - Clinical Trial page.